Discovery & Development

And getting the right people involved from the start. Here’s why collaboration is key for successful clinical development.

How understanding and manipulating senescence dynamics could optimize cancer therapies and improve patient outcomes.

How can you ensure your gene therapy research won’t be slowed down by synthesis problems?

Sitting Down With… Matthew Durdy, Chief Executive, Cell and Gene Therapy Catapult.

How unified assay protocols and advanced bioinformatics are refining our understanding of mitochondrial dysfunction in complex diseases.

The industry is under pressure to reduce the risks of nitrosamines in both in-development and on-market drug products.

Proprietary nanovesicles technology has caught the eye of Eli Lilly. We find out why.

Understanding the role of spatially offset Raman spectroscopy in identifying raw materials, counterfeit medicines, and more.

Cell and Gene therapies have come a long way since the 1970s. Technology, combined with knowledge, will take them even further.

What happens when freezers fail? Experts look at the lessons that can be learned from catastrophic power outages.